NALCN expression is down-regulated and associated with immune infiltration in gastric cancer

BackgroundNALCN has been identified as a tumor suppressor gene, and its role in human cancer progression has garnered significant attention. However, there is a paucity of experimental studies specifically addressing the relationship between NALCN and immune cell infiltration in gastric cancer (GC)....

Full description

Saved in:
Bibliographic Details
Main Authors: Xuewei Li, Na Wu, Chen Wang, Beibei Pei, Xiaoyan Ma, Jun Xie, Wenhui Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1512107/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856593072029696
author Xuewei Li
Xuewei Li
Na Wu
Chen Wang
Beibei Pei
Xiaoyan Ma
Jun Xie
Jun Xie
Wenhui Yang
author_facet Xuewei Li
Xuewei Li
Na Wu
Chen Wang
Beibei Pei
Xiaoyan Ma
Jun Xie
Jun Xie
Wenhui Yang
author_sort Xuewei Li
collection DOAJ
description BackgroundNALCN has been identified as a tumor suppressor gene, and its role in human cancer progression has garnered significant attention. However, there is a paucity of experimental studies specifically addressing the relationship between NALCN and immune cell infiltration in gastric cancer (GC).MethodsThe expression levels of NALCN in tumor tissues, peripheral blood and gastric cancer cells lines from patients with GC were assessed using RNA sequencing, immunohistochemistry (IHC) staining and RT-qPCR. Data obtained from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases were utilized to investigate the correlation between NALCN expression and immune cell infiltration in GC. Subsequently, the relationship between NALCN expression and infiltrating immune cells in GC tissues was examined through immunofluorescence method. Additionally, in vitro experiments were conducted to evaluate the impact of NALCN knockdown on T cells function in GC cell lines.ResultsRNA sequencing analysis revealed that NALCN expression was significantly downregulated in GC tissues. Specifically, NALCN levels were lower in GC tumor tissues and plasma compared to adjacent non-tumor tissues and healthy controls. Consistent with these findings, the expression trend of NALCN mRNA in the GEO database mirrored the experimental results. Mechanistically, NALCN knockdown markedly enhanced cell proliferation, colony formation and migration while reducing apoptosis rates in AGS and GES-1 cells. Analysis of the TCGA database indicated a positive correlation between NALCN expression and the infiltration of B cells, cytotoxic cells, immature dendritic cells (iDC) cells, CD8+ T cells, and others in GC tissue. Conversely, Th17 and Th2 cells infiltration exhibited a negative correlation with NALCN expression. Immunofluorescence staining confirmed that B cells and CD8 T cells were more abundant in GC tumor tissues with high NALCN expression, whereas Th17 and Th2 cells were less prevalent. Subsequently, we co-cultured GC cells transfected with NALCN knockdown or control vectors along with their supernatants with T cells. The results demonstrated that NALCN knockdown in GC cells or their supernatants inhibited T cell proliferation compared to control conditions. Moreover, NALCN may play a role in glucose and glutamine uptake.ConclusionsNALCN facilitates immune cell aggregation in GC and has potential as a biomarker for immune infiltration.
format Article
id doaj-art-71f7d50136514015bb14524d186c5a7c
institution Kabale University
issn 1664-3224
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-71f7d50136514015bb14524d186c5a7c2025-02-12T07:25:38ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-02-011610.3389/fimmu.2025.15121071512107NALCN expression is down-regulated and associated with immune infiltration in gastric cancerXuewei Li0Xuewei Li1Na Wu2Chen Wang3Beibei Pei4Xiaoyan Ma5Jun Xie6Jun Xie7Wenhui Yang8Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Shanxi Medical University, Taiyuan, ChinaMOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan, ChinaDepartment of Digestive Oncology, Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Digestive Oncology, Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Digestive Oncology, Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Digestive Oncology, Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Shanxi Medical University, Taiyuan, ChinaMOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan, ChinaDepartment of Gastroenterology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, ChinaBackgroundNALCN has been identified as a tumor suppressor gene, and its role in human cancer progression has garnered significant attention. However, there is a paucity of experimental studies specifically addressing the relationship between NALCN and immune cell infiltration in gastric cancer (GC).MethodsThe expression levels of NALCN in tumor tissues, peripheral blood and gastric cancer cells lines from patients with GC were assessed using RNA sequencing, immunohistochemistry (IHC) staining and RT-qPCR. Data obtained from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases were utilized to investigate the correlation between NALCN expression and immune cell infiltration in GC. Subsequently, the relationship between NALCN expression and infiltrating immune cells in GC tissues was examined through immunofluorescence method. Additionally, in vitro experiments were conducted to evaluate the impact of NALCN knockdown on T cells function in GC cell lines.ResultsRNA sequencing analysis revealed that NALCN expression was significantly downregulated in GC tissues. Specifically, NALCN levels were lower in GC tumor tissues and plasma compared to adjacent non-tumor tissues and healthy controls. Consistent with these findings, the expression trend of NALCN mRNA in the GEO database mirrored the experimental results. Mechanistically, NALCN knockdown markedly enhanced cell proliferation, colony formation and migration while reducing apoptosis rates in AGS and GES-1 cells. Analysis of the TCGA database indicated a positive correlation between NALCN expression and the infiltration of B cells, cytotoxic cells, immature dendritic cells (iDC) cells, CD8+ T cells, and others in GC tissue. Conversely, Th17 and Th2 cells infiltration exhibited a negative correlation with NALCN expression. Immunofluorescence staining confirmed that B cells and CD8 T cells were more abundant in GC tumor tissues with high NALCN expression, whereas Th17 and Th2 cells were less prevalent. Subsequently, we co-cultured GC cells transfected with NALCN knockdown or control vectors along with their supernatants with T cells. The results demonstrated that NALCN knockdown in GC cells or their supernatants inhibited T cell proliferation compared to control conditions. Moreover, NALCN may play a role in glucose and glutamine uptake.ConclusionsNALCN facilitates immune cell aggregation in GC and has potential as a biomarker for immune infiltration.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1512107/fullNALCNgastric cancer (GC)immune infiltrationtumor immune microenvironment (TIME)biomarker
spellingShingle Xuewei Li
Xuewei Li
Na Wu
Chen Wang
Beibei Pei
Xiaoyan Ma
Jun Xie
Jun Xie
Wenhui Yang
NALCN expression is down-regulated and associated with immune infiltration in gastric cancer
Frontiers in Immunology
NALCN
gastric cancer (GC)
immune infiltration
tumor immune microenvironment (TIME)
biomarker
title NALCN expression is down-regulated and associated with immune infiltration in gastric cancer
title_full NALCN expression is down-regulated and associated with immune infiltration in gastric cancer
title_fullStr NALCN expression is down-regulated and associated with immune infiltration in gastric cancer
title_full_unstemmed NALCN expression is down-regulated and associated with immune infiltration in gastric cancer
title_short NALCN expression is down-regulated and associated with immune infiltration in gastric cancer
title_sort nalcn expression is down regulated and associated with immune infiltration in gastric cancer
topic NALCN
gastric cancer (GC)
immune infiltration
tumor immune microenvironment (TIME)
biomarker
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1512107/full
work_keys_str_mv AT xueweili nalcnexpressionisdownregulatedandassociatedwithimmuneinfiltrationingastriccancer
AT xueweili nalcnexpressionisdownregulatedandassociatedwithimmuneinfiltrationingastriccancer
AT nawu nalcnexpressionisdownregulatedandassociatedwithimmuneinfiltrationingastriccancer
AT chenwang nalcnexpressionisdownregulatedandassociatedwithimmuneinfiltrationingastriccancer
AT beibeipei nalcnexpressionisdownregulatedandassociatedwithimmuneinfiltrationingastriccancer
AT xiaoyanma nalcnexpressionisdownregulatedandassociatedwithimmuneinfiltrationingastriccancer
AT junxie nalcnexpressionisdownregulatedandassociatedwithimmuneinfiltrationingastriccancer
AT junxie nalcnexpressionisdownregulatedandassociatedwithimmuneinfiltrationingastriccancer
AT wenhuiyang nalcnexpressionisdownregulatedandassociatedwithimmuneinfiltrationingastriccancer